EPO Patents = 1

Forward Citations = 61

Loading Chart...

4 inventors (with patents filed for the assignee):

Stephen Mark Robbins (4 out of 8 patents)

Donna Lorraine Senger (4 out of 7 patents)

Jennifer Joy Rahn (4 out of 7 patents)

4. Paul Kubes (2 out of 6 patents)

4 patents: Sort by Forward Citations

1. 11083773 - Peptides that block leukocyte recruitment and methods of use (2021-08-10),

2. 9464114 - Peptides that block leukocyte recruitment and methods of use (2016-10-11),

3. 9095541 - Brain tumor targeting peptides and methods (2015-08-04),

4. 8530429 - Brain tumor targeting peptides and methods (2013-09-10),

Arch Cancer Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative cancer therapies. With a strong pipeline of targeted therapeutics and a commitment to advancing the field of oncology, Arch Cancer Therapeutics is dedicated to improving outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#469 in

#3,376 in Canada

CA

Arch Cancer Therapeutics, Inc.

Forward Citations = 61

4 inventors:

Stephen Mark Robbins (4 out of 8 patents)

Donna Lorraine Senger (4 out of 7 patents)

Jennifer Joy Rahn (4 out of 7 patents)

4. Paul Kubes (2 out of 6 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com